BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2874569)

  • 1. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1785-7. PubMed ID: 2874569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ; Wei ET
    Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM; Kastin AJ
    Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ; Bhargava HN; Wei ET
    Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat.
    Bhargava HN
    Life Sci; 1981 Jul; 29(1):45-51. PubMed ID: 6115301
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs.
    Kastin AJ; Abel DA; Ehrensing RH; Coy DH; Graf MV
    Pharmacol Biochem Behav; 1984 Nov; 21(5):767-71. PubMed ID: 6151196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Oct; 25(4):757-61. PubMed ID: 2878442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of brain dopamine receptors antagonizes the anti-immobility effect of MIF-1 and Tyr-MIF-1 in rats.
    Pulvirenti L; Kastin AJ
    Eur J Pharmacol; 1988 Jul; 151(2):289-92. PubMed ID: 2901971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyr-MIF-1 affects passive avoidance behavior but not motor activity in rats.
    Hayashi T; Kastin AJ; Coy DH; Olson RD
    Brain Res Bull; 1983 Dec; 11(6):659-62. PubMed ID: 6140994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats.
    Hayashi T; Fischman AJ; Kastin AJ; Coy DH
    Pharmacol Biochem Behav; 1984 Nov; 21(5):809-12. PubMed ID: 6151198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on GH, LH, prolactin, FSH, and TSH secretion in rats with and without morphine.
    Krowicki ZK; Kastin AJ
    Neuropeptides; 1991 Jan; 18(1):41-7. PubMed ID: 1675454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
    Björkman S; Castensson S; Sievertsson H
    J Med Chem; 1979 Aug; 22(8):931-5. PubMed ID: 40028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of Tyr-MIF-1 stimulates gastrointestinal motility in rats: evidence for the involvement of dopamine, sigma and CCK receptors.
    Million M; Fioramonti J; Bueno L
    Neuropeptides; 1994 Feb; 26(2):77-85. PubMed ID: 7909585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.